Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • quicksand21
    Junior Member
    • May 2010
    • 6

    #1

    Complete Genomics Variant Calls

    Hello,

    I was wondering if anyone could shed some light on the totalScore column in the VAR files produced by Complete Genomics? Specifically what do these scores mean? Is there a best practice in terms of thresholding for high confidence variants?

    Thank you in advance for your advice!
  • jason.laramie
    Junior Member
    • Feb 2011
    • 3

    #2
    Hi,
    The totalScore is a likelihood ratio test between the most likely hypothesis (e.g. genotype) and the next most likely, and we express this score in decibels (dB). Bioinformaticists will recognize dB as the basis of the Phred scale: 10 dB means the likelihood ratio is 10:1, 20 dB means 100:1, 30 dB is 1000:1, etc. The variant scores factor in quantity of evidence (read depth), quality of evidence (base call quality values), and mapping probabilities. Therefore, the score measures our confidence in calling the variant. Likewise, we produce a "refScore" value that is calculated in a similar fashion but with the numerator of the likelihood being set to homozygous reference. Finally, the refScore can be used to ask how confident we are in the position being homozygous reference (e.g. high scores = high confidence) and if not homozygous reference the totalScore will then ask how confident are we in the genotype we called.

    Scores for variants are not calibrated on an absolute scale to error rate. A score of 30 dB does not necessarily indicate that the P(error)=0.001.

    20 dB is presently the minimum score for calling a homozygous variant and 40dB is for a heterozygous variant. Based on empirical testing, these thresholds were chosen to balance call-rate accuracy. Additionally, we add another layer of calls into our assembly process which is the "no-call". Therefore, a call can be homozygous ref, something else, or no-call. The no-call results from one hypothesis not being well separated from the other hypothesizes (>20dB) and, therefore, not sure what the correct answer is.

    As for best practices, since we have thresholded these as mentioned above and generated "no-calls" when the information is not well separated for each hypothesis, most of our customers take the genotype calls "as is" without applying another filter.

    Jason Laramie, PhD
    Principal Field Application Scientist
    Complete Genomics, Inc
    Jason Laramie, PhD
    Principal Application Scientist
    Complete Genomics, Inc.

    Comment

    • karenliu
      Junior Member
      • Oct 2011
      • 1

      #3
      Hi Jason,

      A follow up question to your answer: you said
      20 dB is presently the minimum score for calling a homozygous variant and 40dB is for a heterozygous variant
      I see that each allele in a diploid locus is called separately. For example, I can have a genotype AN or GN or NN. Namely, no-calls are determined per allele bases. If this is the case, what does the homozygous vs. heterozygous variant mean in your definition above?

      Thanks.
      Karen Liu

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...